Average cost of drugs for extensively drug-resistant tuberculosis in Ghana
Ghana: Average cost of drugs for extensively drug-resistant tuberculosis was 800 constant 2022 US$ in 2024. ▼ Falling
Latest (2024)
800 constant 2022 US$
Change on year
up 50.9%
World rank
47th
of 56 countries
All-time high
2,500 constant 2022 US$
in 2019
All-time low
530 constant 2022 US$
in 2023
Years of data
7
2018–2024
Average cost of drugs for extensively drug-resistant tuberculosis in Ghana, 2018–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
Ghana recorded 800 constant 2022 US$ for average cost of drugs for extensively drug-resistant tuberculosis in 2024.
Compared with earlier readings it is up 50.9% on the previous year and down 46.7% over ten years.
That places Ghana 47th out of 56 countries with data for 2024, putting it in the bottom quarter.
Average cost of drugs for extensively drug-resistant tuberculosis in Ghana, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2018 | 1,500 constant 2022 US$ | — |
| 2019 | 2,500 constant 2022 US$ | +66.7% |
| 2020 | 2,100 constant 2022 US$ | -16.0% |
| 2021 | 2,100 constant 2022 US$ | +0.0% |
| 2022 | 2,100 constant 2022 US$ | +0.0% |
| 2023 | 530 constant 2022 US$ | -74.8% |
| 2024 | 800 constant 2022 US$ | +50.9% |
Ghana compared with similar countries
- Ghana's 800 constant 2022 US$ is below the median for lower middle income countries, which is 1,525 constant 2022 US$, 52% of the median. (24 countries reporting)
- Ghana's 800 constant 2022 US$ is below the median for Sub-Saharan Africa, which is 1,500 constant 2022 US$, 53% of the median. (20 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 2,000 constant 2022 US$ | 1,500 constant 2022 US$ | 2,500 constant 2022 US$ | 2 |
| 2020s | 1,526 constant 2022 US$ | 530 constant 2022 US$ | 2,100 constant 2022 US$ | 5 |
Countries ranked near Ghana
More reference data data for Ghana
- Emission Totals - Indirect emissions (N2O) - Manure applied to Soils 0.2805 (2050)
- Emission Totals - Indirect emissions (N2O) - Manure left on Pasture 1.89 (2050)
- Emission Totals - Indirect emissions (N2O) - IPCC Agriculture 2.69 (2050)
- Emission Totals - Indirect emissions (N2O) - Crop Residues 0.1989 (2050)
- Emission Totals - Indirect emissions (N2O) - Agricultural Soils 2.69 (2050)
- Emission Totals - Emissions (N2O) - Manure applied to Soils 0.9405 (2050)
- Emission Totals - Emissions (N2O) - Manure Management 0.9478 (2050)
- Emission Totals - Emissions (N2O) - Manure left on Pasture 8.22 (2050)
- Emission Totals - Emissions (N2O) - IPCC Agriculture 12.64 (2050)
- Emission Totals - Emissions (N2O) - Crop Residues 1.08 (2050)
Frequently asked questions
- What is average cost of drugs for extensively drug-resistant tuberculosis in Ghana?
- Average cost of drugs for extensively drug-resistant tuberculosis in Ghana was 800 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of drugs for extensively drug-resistant tuberculosis recorded in Ghana?
- The highest recorded value was 2,500 constant 2022 US$ in 2019.
- What is the lowest average cost of drugs for extensively drug-resistant tuberculosis recorded in Ghana?
- The lowest recorded value was 530 constant 2022 US$ in 2023.
- How does Ghana rank for average cost of drugs for extensively drug-resistant tuberculosis?
- Ghana ranks 47th out of 56 countries with data for 2024.
- Is average cost of drugs for extensively drug-resistant tuberculosis rising or falling in Ghana?
- Over the last ten years it is down 46.7%. The long-run trend across the full record is falling.
- Where does this Ghana data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 7 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.